ReadMap: Reading in Stroke Alexia and Typical Aging
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Georgetown University
- Study ID
- NCT06700005
- Status
- Recruiting
Conditions
- Alexia
- Aphasia
- Stroke
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
Loss of reading ability due to stroke, called alexia, likely affects over a million Americans at any given time and causes difficulty performing many daily life functions, such as paying bills, using email/text, reading for pleasure, and reading signs in the community. Understanding the brain and cognitive basis of alexia could improve diagnosis and treatment of this important problem. In this study, the investigators will perform a large-scale behavioral and brain imaging study of stroke survivors and typical older adults to improve our understanding of the brain and cognitive basis of reading in both of these groups. Participants will complete a battery of tests of reading, speech, language, and thinking abilities. In addition, some participants will complete an MRI. Sessions will be completed across approximately 2-6 weeks, but may be extended depending on participants' schedules and availability. Some participants will be invited to repeat these procedures once or twice in approximately 3-12 months to monitor for changes in reading abilities and MRI measurements over time.
Key Dates
- Start date
- Jan 12, 2023
- Status verified
- Oct 2024
- Primary completion
- Aug 31, 2028
- Completion
- Aug 31, 2028
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: Stroke SurvivorsParticipants have had a left-hemisphere stroke, or a stroke elsewhere in the brain causing aphasia or alexia (i.e., reading difficulties). They are given a series of standardized and in-house tests of reading, language and cognition to provide a detailed profile of strengths and weaknesses, plus an MRI.
- Arm: ControlsParticipants are matched to the stroke cohort in age, educational background, race, and gender but have no history of brain injury. They are also given a series of standardized and in-house tests of reading, language and cognition to provide a detailed profile of strengths and weaknesses, plus an MRI.
Primary Outcome Measure
MP-RAGE (Magnetization Prepared Rapid Acquisition Gradient Echo) [ Time Frame: Collected within 1 month of behavioral testing ]
Central Contacts
- Alycia Laks, MS, CCC-SLP202-687-5205
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20057 |
Find similar trials in Washington D.C., DC
Related Studies
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- The CONFORM Pivotal TrialRecruiting · Conformal Medical, Inc · Birmingham, Alabama
- Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield TrialsRecruiting · University of Cincinnati · Birmingham, Alabama
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis- Magnetic Resonance ImagingRecruiting · Yale University · Birmingham, Alabama